Figure 1.
The model for the mechanistic pathway of drug response consists of: a pharmacokinetic (PK) model for the dose–exposure relationship, a pharmacokinetic biomarker model for the exposure–biomarker relationship and biomarker clinical end-point model for the biomarker–clinical end-point relationship and a pharmacokinetic toxicity (Tox) model for the exposure–toxicity relationship.